<DOC>
	<DOC>NCT00631696</DOC>
	<brief_summary>This study is being performed as a Phase IV FDA commitment study and is being powered adequately to assess changes in sperm concentration, FSH and testosterone in healthy male subjects treated with pregabalin as compared to placebo, in addition to confirming lack of effects on sperm motility.</brief_summary>
	<brief_title>Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo</brief_title>
	<detailed_description>This is a Phase 4 FDA commitment study. The purpose of the study is to evaluate the effects of pregabalin as compared to placebo on sperm concentration in healthy male subjects</detailed_description>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Healthy 18 to 55 years old males Screening sperm count &lt;20 x 106/mL; screening sperm motility &lt;50% motile (a+b) or &lt;25% Class "a" motile or screening sperm morphology &lt;30% normal or semen volume &lt;1.5 mL or white blood cell count &gt;1 x 106 /mL on any screening visit sample</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Healthy males Human volunteers pregabalin or placebo sperm quality and quantity</keyword>
</DOC>